NYC hospital launches innovation center

A newly launched innovation center will focus on both new treatments and tools for musculoskeletal conditions as well as care delivery innovations.

The Hospital for Special Surgery (HSS), which has focused on orthopedics and rheumatology since 1863, launched the HSS Innovation Center to "identify and support the next generation of cutting-edge medical and scientific technology that will improve clinical outcomes, enhance the patient experience and lower the cost to deliver care in a meaningful way."

The center, which brings together the people, infrastructure and finances to support the acceleration and commercialization of early-stage technologies, will work "to bridge the gap between applied research and product development while adhering to the high quality standards of HSS," according to an article on the hospital's website.

"There is enormous opportunity right now to develop innovative solutions in healthcare that not only result in improved outcomes, but in lower costs and more patient-centered care,” said Robert Hotchkiss, MD, orthopedic surgeon, and Hospital for Special Surgery’s first-ever chief innovation officer. “With our expertise and singular focus in orthopedics and its related disciplines, we’re uniquely positioned to further develop breakthroughs in musculoskeletal medicine that can benefit patients around the world."

"Innovation is at the core of the HSS mission and by investing in new developments and discoveries we reaffirm our commitment to successful patient outcomes, research advancements and high quality specialized care,” said Louis A. Shapiro, president and CEO. “This initiative is crucially important to the future of not only our organization, but orthopedics on a global scale."

The HSS Innovation Center encompasses traditional biomedical science and technology products including implants, medication and biomaterials, but also new care delivery innovations including process innovations, digital health solutions, wearable technology and telemedicine.

The HSS Innovation Center also will offer opportunities to license HSS portfolio technologies, invest capital in HSS startup businesses, pilot products and services through the HSS Accelerator program and support the center’s overall mission through corporate and philanthropic sponsorship of the fund.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup